The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Anticipated Rise In Market Value Of The Sepsis Market During The Forecast Period?
The sepsis market has experienced significant expansion in recent years. Its valuation is projected to increase from $1.02 billion in 2025 to $1.11 billion by 2026, representing a compound annual growth rate (CAGR) of 9.0%. The growth observed in the past can be attributed to a high incidence of sepsis, enhanced hospital care standards, the adoption of specific clinical protocols, the establishment of sepsis awareness initiatives, and advanced ICU facilities.
The sepsis market is projected for robust expansion over the coming years, reaching $1.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This anticipated growth during the forecast timeframe is driven by factors such as AI-supported early diagnostic methods, the increasing availability of point-of-care monitoring, seamless integration with Electronic Health Record (EHR) systems, novel therapeutic options for sepsis, and the widespread adoption of international sepsis management protocols. Key developments anticipated within this period encompass innovative tools for early sepsis detection, risk assessment powered by artificial intelligence, portable sepsis monitoring devices, the incorporation of tele-ICU systems, and standardized, protocol-based treatment approaches.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21286&type=smp
What Primary Drivers Are Shaping The Sepsis Market?
The escalating burden of infectious diseases is projected to stimulate the expansion of the sepsis market moving forward. Infectious diseases are conditions originating from the infiltration of the body by bacteria, viruses, fungi, or parasites. Well-known infectious diseases, such as tuberculosis, flu, ringworm, and malaria, spread through direct contact, contaminated sources, or insect vectors. The rising occurrence of these diseases is attributed to population growth, globalization, environmental alterations, the development of drug-resistant pathogens, and shortcomings in healthcare infrastructure. Sepsis, a severe complication of infectious diseases, results from the body’s extreme immune response to infections, leading to widespread inflammation and potential organ damage. For example, according to the Centers for Disease Control and Prevention, a US-based government agency for public health, it was reported in November 2024 that the United States recorded 9,633 cases of tuberculosis (TB) in 2023, indicating a 15.6% increase from the 8,332 cases reported in 2022. Therefore, the increasing prevalence of infectious diseases is a key factor driving the growth of the sepsis market.
How Are Segments Identified Within The Sepsis Market Segment Framework?
The sepsis market covered in this report is segmented –
1) By Type: Diagnosis, Therapeutics
2) By Pathogen: Bacterial, Viral, Fungal
3) By Application: Severe Sepsis, Septic Shock
4) By End User: Hospitals, Pathology, Reference Laboratories
Subsegments:
1) By Diagnosis: Blood Tests, Imaging Techniques, Microbiological Culture Tests, Biomarker Tests, Other Diagnostic Methods
2) By Therapeutics: Antibiotics, Antifungal Agents, Vasopressors, Immunoglobulins, Corticosteroids, Other Therapeutic Options
What Trends Are Affecting The Growth Of The Sepsis Market?
Key companies within the sepsis market are concentrating on creating technologically advanced systems, including those driven by artificial intelligence (AI), to facilitate earlier diagnosis, refine treatment accuracy, and forecast patient outcomes. The ultimate goal is to lessen mortality rates and enhance healthcare efficiency in sepsis management. As an illustration, in June 2024, Predicate Healthcare Performance Group (HPG), a US-based healthcare entity, unveiled its AI software platform, OpenDX. This novel platform merges AI-powered diagnostics with wearable biosensors, empowering healthcare providers to identify initial indicators of sepsis. This not only assists in sepsis diagnosis but also holds the capacity for expansion into other health conditions, emphasizing the critical role of technology in diagnostics. Predicate’s chest sensor specifically assists healthcare personnel in detecting early sepsis signs, a diagnosis often difficult to make and frequently overlooked.
Who Are The Companies Competing Within The Sepsis Market?
Major companies operating in the sepsis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck KGaA, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Asahi Kasei Corporation, Becton Dickinson and Company, bioMérieux SA, QuidelOrtho Corporation, DiaSorin S.p.A., Seegene Inc., EKF Diagnostics, Boditech Med Inc., Cytovale Inc., Alifax S.r.l., Hansa Biopharma, Amomed Pharma GmbH, Inotrem S.A., Abionic SA, Biosystems Inc., Immunexpress Inc.
Get The Full Sepsis Market Report:
https://www.thebusinessresearchcompany.com/report/sepsis-global-market-report
Which Region Has The Greatest Market Share In The Sepsis Market?
North America was the largest region in the sepsis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sepsis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Sepsis Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/sepsis-global-market-report
Browse Through More Reports Similar to the Global Sepsis Market 2026, By The Business Research Company
Infectious Disease Diagnostics Testing Market Report 2026
Hemostasis Diagnostic Devices And Equipment Market Report
Gastrointestinal Pathogen Testing Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model